PHILADELPHIA, Jan. 17, 2024 /PRNewswire/ -- Vistia Health, a healthcare navigator supporting whole-person health journeys, today announced that it has selected Progyny, Inc. to be the preferred fertility and family building benefits provider for Vistia Health clients. Progyny, Inc (Nasdaq: PGNY) is a leading benefits management company specializing in fertility and family building benefits solutions.
Visita Health clients, which include one of the largest health plans in Southeastern Pennsylvania, can now experience a streamlined implementation and the ease of a fully integrated solution when they elect to include comprehensive fertility and family building support in their benefits program.
One in six people globally are now affected by infertility, as reported by the World Health Organization. The growing prevalence of infertility underscores the need for support and accessible care, and employers are recognizing the need for this type of benefit. A recent Mercer survey found that 60% of employers offer some sort of fertility coverage. Moreover, approximately 40% of employers have taken steps to provide equitable family building benefits, supporting diverse family structures.
"We've seen strong demand for family building benefits as clients begin to further recognize the diverse needs of individuals embarking on their family building journeys," said Dave Stefanski, director, Vistia Health. "By partnering with Progyny, our clients and their employees will benefit from its comprehensive and inclusive family building solution. Progyny offers access to premier fertility experts and personalized concierge support as well as a fertility and family building journey with superior clinical outcomes – like healthier pregnancies and babies."
"Vistia Health and Progyny share a common goal of providing employers with impactful, outcomes-based healthcare solutions. We're excited to partner with Vistia Health as its preferred fertility and family building solution," said Michael Sturmer, Progyny president. "The decision to start or build a family is a deeply personal one and can be especially complex for those facing infertility or other hurdles. Our shared commitment with Vistia Health ensures tailored, compassionate support for individuals and couples, empowering them on their unique journeys."
Vistia Health clients electing Progyny's solution can expect:
To learn more about the Vistia Health partnership with Progyny, visit: vistiahealth.com
About Vistia Health
Vistia Health reduces the complexity of health care through care coordination and navigation solutions that guide and support consumers on their journey to whole health. Using personalized insights and tailored engagement, we meet the needs of individuals, while contributing to enhancing clinical outcomes and improving affordability to maximize value of care. Visit us at vistiahealth.com.
About Progyny
Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women's health solution, trusted by the nation's leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times, INC. 5000, Inc Power Partners and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
Contact:
Kathleen Conlon
This email address is being protected from spambots. You need JavaScript enabled to view it.
Alexis Ford
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$14.41 |
Daily Change: | 0.43 3.08 |
Daily Volume: | 102,550 |
Market Cap: | US$1.300B |
November 14, 2024 November 12, 2024 August 06, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB